Taxonomy of rare genetic metabolic bone disorders

作者: L. Masi , D. Agnusdei , J. Bilezikian , D. Chappard , R. Chapurlat

DOI: 10.1007/S00198-015-3188-9

关键词: Orphan drugOsteoporosisOsteoclastImmunologyOsteopetrosisPhenotypeRheumatologyMetabolic Bone DisorderMedicineInternal medicineBone remodeling

摘要: This article reports a taxonomic classification of rare skeletal diseases based on metabolic phenotypes. It was prepared by The Skeletal Rare Diseases Working Group the International Osteoporosis Foundation (IOF) and includes 116 OMIM phenotypes with 86 affected genes. comprise group commonly associated severe clinical consequences. In recent years, description radiographic features several genetic bone disorders paralleled discovery key molecular pathways involved in regulation mineral metabolism. Including this information may improve recognition management patients. IOF recognized need formed (SRD-WG) basic scientists who developed taxonomy their pathogenesis. (RGMBDs) comprises phenotypes, genes related to homeostasis. were divided into four major groups, namely, due altered osteoclast, osteoblast, or osteocyte activity; matrix proteins; microenvironmental regulators; deranged calciotropic hormonal activity. provides first comprehensive will help development common shared diagnostic therapeutic for these patients also creation international registries diseases, step tests next generation sequencing performing large intervention trials assess efficacy orphan drugs.

参考文章(73)
LC Hofbauer, CA Kuhne, V Viereck, The OPG/RANKL/RANK system in metabolic bone diseases. Journal of Musculoskeletal & Neuronal Interactions. ,vol. 4, pp. 268- 275 ,(2004)
Genetics of Bone Biology and Skeletal Disease Published in <b>2013</b> by Academic Press. ,(2012) , 10.1016/C2010-0-67110-0
Adele L. Boskey, Pamela Gehron Robey, The Composition of Bone Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Eighth Edition. pp. 49- 58 ,(2013) , 10.1002/9781118453926.CH6
John Forman, Domenica Taruscio, Virginia A. Llera, Luis A. Barrera, Timothy R. Coté, Catarina Edfjäll, Désirée Gavhed, Marlene E. Haffner, Yukiko Nishimura, Manuel Posada, Erik Tambuyzer, Stephen C. Groft, Jan‐Inge Henter, , The need for worldwide policy and action plans for rare diseases Acta Paediatrica. ,vol. 101, pp. 805- 807 ,(2012) , 10.1111/J.1651-2227.2012.02705.X
Richard W. Keen, Sclerosing and Dysplastic Bone Diseases John Wiley & Sons, Inc.. pp. 767- 768 ,(2013) , 10.1002/9781118453926.PART8
Markus J Seibel, Biochemical Markers of Bone Turnover Part I: Biochemistry and Variability The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists.. ,vol. 26, pp. 97- 122 ,(2005)
F. Patrick Ross, Osteoclast Biology and Bone Resorption Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Eighth Edition. pp. 25- 33 ,(2013) , 10.1002/9781118453926.CH3
W J Burtis, T Wu, C Bunch, J J Wysolmerski, K L Insogna, E C Weir, A E Broadus, A F Stewart, Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. Journal of Biological Chemistry. ,vol. 262, pp. 7151- 7156 ,(1987) , 10.1016/S0021-9258(18)48217-8
Ségolène Aymé, J. Schmidtke, Networking for rare diseases: a necessity for Europe Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. ,vol. 50, pp. 1477- 1483 ,(2007) , 10.1007/S00103-007-0381-9
Annalisa Frattini, Paul J. Orchard, Cristina Sobacchi, Silvia Giliani, Mario Abinun, Jan P. Mattsson, David J. Keeling, Ann-Katrin Andersson, Pia Wallbrandt, Luigi Zecca, Luigi D. Notarangelo, Paolo Vezzoni, Anna Villa, Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nature Genetics. ,vol. 25, pp. 343- 346 ,(2000) , 10.1038/77131